These results observed in immune-oncology research suggest that studying the relationship between cDC2s and regulatory T cells and/or between ISG+ cDC2s and CD8+ T cells may be informative to elucidate the pathogenesis of ACD. Here, CD8A is linked to granular corneal dystrophy type II.